The FDA has Granted Approval to Pfizer for its Inaugural Gene Therapy Targeting a Rare Hereditary Bleeding Disorder
The Food and Drug Administration (FDA) announced its approval of Pfizer's treatment for a rare genetic bleeding disorder, marking the company's first gene therapy to gain clearance in the U.S.…